Work

Supplementary Data from Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Data from Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab

DOI: 10.1158/1078-0432.22441663.v1

Authors: Howard M. Stern, Mary Padilla, Klaus Wagner, Lukas Amler, Avi Ashkenazi

Language: English

Topic: Glycosylation and Glycoproteins Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362426505

Cites:

Cited by:

Related to: 10